Teva Pharmaceutical Indus

DividendsTeva Pharmaceutical Indus

TEVA

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding Date
Payment
Value ($)
Frequency
11/27/2017
12/12/2017
0,085
Quarterly
8/25/2017
9/14/2017
0,085
Quarterly
6/1/2017
6/22/2017
0,34
Quarterly
2/28/2017
3/20/2017
0,34
Quarterly
12/1/2016
12/20/2016
0,34
Quarterly
8/18/2016
9/8/2016
0,34
Quarterly
5/20/2016
6/7/2016
0,34
Quarterly
2/25/2016
3/14/2016
0,34
Quarterly
11/13/2015
12/3/2015
0,34
Quarterly
8/18/2015
9/3/2015
0,34
Quarterly
5/15/2015
6/4/2015
0,34
Quarterly
2/17/2015
3/3/2015
0,34
Quarterly
11/13/2014
12/2/2014
0,32
Quarterly
8/19/2014
9/4/2014
0,353
Quarterly
5/16/2014
6/2/2014
0,35
Quarterly
2/20/2014
3/10/2014
0,345
Quarterly
1/9